Exploring how fentanyl causes severe breathing problems and death in rats.
Identifying novel molecular targets, signaling pathways and mechanisms underlying fentanyl overdose-induced severe respiratory depression and lethality in rats using TMT phosphoproteomics/proteomics
This study is looking at how fentanyl affects breathing and can lead to serious problems, using rat models to learn more about the body's responses, which could help develop better treatments for people who overdose on opioids.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10831163 on NIH RePORTER |
What this research studies
This research investigates the molecular targets and signaling pathways involved in severe respiratory depression and lethality caused by fentanyl overdose using advanced techniques like TMT phosphoproteomics and proteomics. By studying rat models, the research aims to understand how fentanyl affects respiratory regulation and the role of mu opioid receptors and other mechanisms in this process. The findings could provide insights into the complex interactions between opioids and the respiratory system, potentially leading to improved treatments for overdose situations.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk of opioid overdose, particularly those using fentanyl or similar potent opioids.
Not a fit: Patients who are not using opioids or are not at risk of overdose may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of fentanyl overdoses, ultimately saving lives.
How similar studies have performed: Other research has shown success in understanding opioid-induced respiratory depression, but this specific approach using TMT phosphoproteomics is relatively novel.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Pan, Ying-Xian — Rutgers Biomedical and Health Sciences
- Study coordinator: Pan, Ying-Xian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.